These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31039251)

  • 21. In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex.
    Brown-Elliott BA; Philley JV; Griffith DE; Thakkar F; Wallace RJ
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
    Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ
    Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpoints.
    Fratoni AJ; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2022 Mar; 77(4):1052-1060. PubMed ID: 35134195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease.
    Ferro BE; Srivastava S; Deshpande D; Pasipanodya JG; van Soolingen D; Mouton JW; van Ingen J; Gumbo T
    Antimicrob Agents Chemother; 2016 May; 60(5):2895-900. PubMed ID: 26926649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.
    Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Aralar P; Young LS
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2210-4. PubMed ID: 11451676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Rifamycins for Efficacy Against
    Boorgula GD; Jakkula LUMR; Gumbo T; Jung B; Srivastava S
    Front Pharmacol; 2021; 12():645264. PubMed ID: 33935740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC; Wu MF; Chen HC; Huang WC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the Genotype and Drug Susceptibilities between Mycobacterium avium and Mycobacterium intracellulare in China.
    Zheng HW; Pang Y; He GX; Song YY; Zhao YL
    Biomed Environ Sci; 2017 Jul; 30(7):517-525. PubMed ID: 28756811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An
    Sonawane VV; Ruth MM; Pennings LJ; Svensson EM; Wertheim HFL; Hoefsloot W; van Ingen J
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0273020. PubMed ID: 33972258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterium avium complex infection. Pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes.
    Peloquin CA
    Clin Pharmacokinet; 1997 Feb; 32(2):132-44. PubMed ID: 9068928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
    Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Barbara-Burnham L; Young LS
    Antimicrob Agents Chemother; 1996 Mar; 40(3):546-51. PubMed ID: 8851568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The beige mouse model for Mycobacterium avium complex (MAC) disease: optimal conditions for the host and parasite.
    Gangadharam PR; Perumal VK; Farhi DC; LaBrecque J
    Tubercle; 1989 Dec; 70(4):257-71. PubMed ID: 2626803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thioridazine Is an Efflux Pump Inhibitor in Mycobacterium avium Complex but of Limited Clinical Relevance.
    Ruth MM; Pennings LJ; Koeken VACM; Schildkraut JA; Hashemi A; Wertheim HFL; Hoefsloot W; van Ingen J
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimum inhibitory concentration distributions for Mycobacterium avium complex-towards evidence-based susceptibility breakpoints.
    Schön T; Chryssanthou E
    Int J Infect Dis; 2017 Feb; 55():122-124. PubMed ID: 28069470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of a Novel Regimen of Rifapentine, Tedizolid, and Minocycline with Standard Regimens for Treatment of Pulmonary Mycobacterium kansasii.
    Chapagain M; Gumbo T; Heysell SK; Srivastava S
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32690646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.
    Lee MR; Chien JY; Huang YT; Liao CH; Shu CC; Yu CJ; Hsueh PR
    Int J Antimicrob Agents; 2017 Jul; 50(1):35-40. PubMed ID: 28478210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
    Sato K; Tomioka H; Akaki T; Kawahara S
    Int J Antimicrob Agents; 2000 Sep; 16(1):25-9. PubMed ID: 11185410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistance profile of human Mycobacterium avium complex strains from India.
    Venugopal D; Kumar S; Isa M; Bose M
    Indian J Med Microbiol; 2007 Apr; 25(2):115-20. PubMed ID: 17582180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Mycobacterium avium-intracellulare complex: a great leap forward.
    Alffenaar JC; van Ingen J
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i1-i2. PubMed ID: 28922812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.